Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Calculi Dissolution Agent [EPC]
Sodium Phosphate, Monobasic is an electrolyte and urinary acidifier used primarily as a calculi dissolution agent to prevent kidney stones and manage phosphorus levels.
Name
Sodium Phosphate, Monobasic
Raw Name
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Category
Calculi Dissolution Agent [EPC]
Salt Form
Monohydrate
Drug Count
34
Variant Count
54
Last Verified
February 17, 2026
RxCUI
800644, 800648, 1047786, 1087457, 283100, 2637557, 2640308, 1872384, 1872443, 1872447, 200251, 1050325, 1048336, 1048340, 1251290, 1251241, 730955
UNII
JAC85A2161, XF417D3PSL, LX22YL083G, 593YOG76RN, B22547B95K, 02F3473H9O, 4J9FJ0HL51, 660YQ98I10, TU7HW0W0QT, F2R8V82B84, J50OIX95QV, T42P99266K, 28A37T47QO, 2968PHW8QP, 1Q73Q2JULR, 5QWK665956, 70WT22SF4B, 3980JIH2SW, 4550K0SC9B, 451W47IQ8X, GR686LBA74, 22ADO53M6F, 5A614L51CT, POD38AIF08, OB570Z127K, 8NAP7826UB
About Sodium Phosphate, Monobasic
Sodium Phosphate, Monobasic is an electrolyte and urinary acidifier used primarily as a calculi dissolution agent to prevent kidney stones and manage phosphorus levels.
Detailed information about Sodium Phosphate, Monobasic
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sodium Phosphate, Monobasic.
Historically, sodium phosphate salts have been staples in clinical medicine for decades. Sodium Phosphate, Monobasic is frequently used in combination with its sister salt, Sodium Phosphate, Dibasic, to create buffered solutions that maintain a specific pH. This buffering capacity is essential not only in oral and intravenous medications but also in laboratory settings and as an anticoagulant in blood processing. While it is a naturally occurring mineral salt, its concentrated pharmaceutical application requires precise medical supervision to avoid significant disruptions in the body's delicate mineral balance. Your healthcare provider may prescribe this agent to alter the chemical environment of your urinary tract, making it less hospitable for the crystallization of minerals that lead to painful stones.
At the molecular level, Sodium Phosphate, Monobasic functions by dissociating into sodium ions (Na+) and phosphate ions (H2PO4-). The primary therapeutic action is driven by the phosphate ion. In the context of its role as a Calculi Dissolution Agent, the mechanism is two-fold: acidification and calcium chelation.
When ingested or administered, the monobasic form of sodium phosphate acts as a weak acid. As the kidneys filter these ions into the urine, they increase the concentration of hydrogen ions, thereby lowering the urinary pH (making it more acidic). This acidic environment is critical for patients prone to calcium phosphate stones, as these stones typically form in alkaline (basic) urine. By shifting the pH, the drug helps keep these minerals in a dissolved state, preventing them from aggregating into solid masses.
Furthermore, the increased presence of phosphate in the urine can lead to calcium chelating activity. Phosphate ions have a high affinity for calcium ions. By binding to calcium in the urinary tract, the phosphate prevents the calcium from binding with oxalate—the most common component of kidney stones. This competitive binding reduces the saturation of calcium oxalate, further inhibiting stone formation. In patients with hypophosphatemia, the drug simply restores the necessary intracellular and extracellular levels of phosphorus required for ATP (adenosine triphosphate) production, bone mineralization, and cellular signaling.
Understanding how the body processes Sodium Phosphate, Monobasic is vital for ensuring therapeutic efficacy and safety.
Sodium Phosphate, Monobasic has several FDA-approved and clinically recognized indications:
Sodium Phosphate, Monobasic is rarely found as a standalone single-ingredient product for patients; it is almost always part of a buffered formulation. Common forms include:
> Important: Only your healthcare provider can determine if Sodium Phosphate, Monobasic is right for your specific condition. The balance of electrolytes in your body is complex, and improper use can lead to serious cardiac or renal complications.
The dosage of Sodium Phosphate, Monobasic is highly individualized and depends strictly on the indication being treated and the patient's baseline electrolyte levels.
Sodium Phosphate, Monobasic must be used with extreme caution in children.
Patients with impaired kidney function (decreased GFR) require significant dose reductions. Because the kidneys are the primary route of phosphate elimination, even standard doses can lead to toxic accumulations (hyperphosphatemia) in those with Stage 3, 4, or 5 Chronic Kidney Disease. In many cases of severe renal failure, this medication is contraindicated.
No specific dosage adjustments are typically required for patients with liver disease, as the drug is not metabolized by the liver. However, if hepatic impairment is accompanied by hepatorenal syndrome, the renal guidelines must be followed.
Older adults should start at the lower end of the dosing spectrum. Clinical studies indicate that the elderly are more susceptible to "acute phosphate nephropathy" (sudden kidney failure) and electrolyte shifts, particularly if they are also taking diuretics or blood pressure medications.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not "double up" or take two doses at once, as this can cause a sudden spike in phosphate levels, potentially leading to calcium drops and muscle cramping.
An overdose of Sodium Phosphate, Monobasic is a medical emergency. Signs of overdose include:
In case of suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment usually involves aggressive intravenous hydration and medications to lower phosphate levels or restore calcium balance.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as this could lead to a recurrence of kidney stones or electrolyte instability.
Most patients taking Sodium Phosphate, Monobasic for urinary acidification or phosphorus replacement will experience some degree of gastrointestinal discomfort. These side effects are typically dose-dependent and may include:
> Warning: Stop taking Sodium Phosphate, Monobasic and call your doctor immediately if you experience any of the following symptoms. These may indicate a life-threatening electrolyte imbalance or organ damage.
When taken over months or years, Sodium Phosphate, Monobasic can lead to complications that require ongoing monitoring:
While Sodium Phosphate, Monobasic as a standalone agent for stone prevention does not always carry a black box warning, the FDA has issued a Black Box Warning for oral sodium phosphate products used for bowel cleansing (e.g., Visicol, OsmoPrep).
Summary of Warning: There have been rare but serious reports of acute phosphate nephropathy (a type of acute kidney failure) in patients using these products for colonoscopy preparation. Some cases resulted in permanent impairment of kidney function and required long-term dialysis. Risk factors include being over age 55, having pre-existing kidney disease, dehydration, or taking certain medications like ACE inhibitors, ARBs, or NSAIDs.
Report any unusual symptoms, particularly changes in urination or swelling, to your healthcare provider immediately.
Sodium Phosphate, Monobasic is a potent metabolic modifier. It is not a simple mineral supplement and should be treated with the same caution as any prescription medication. The primary safety concern involves the delicate balance between phosphorus and calcium. Because these two minerals have an inverse relationship in the blood, increasing one can dangerously lower the other. Patients must remain well-hydrated throughout treatment to help the kidneys process the increased mineral load.
As noted previously, the FDA has mandated a Black Box Warning for high-dose sodium phosphate products used for bowel evacuation. The warning highlights the risk of Acute Phosphate Nephropathy. For patients taking lower daily doses for calculi dissolution, the risk is lower but still present, especially if the patient becomes dehydrated or has underlying renal vulnerability. No patient should use these products for bowel cleansing without a specific prescription and a review of their kidney function.
If you are taking Sodium Phosphate, Monobasic long-term, your healthcare provider will require regular laboratory testing. These typically include:
This medication generally does not cause impairment. However, if you experience dizziness or lightheadedness due to electrolyte shifts or dehydration, you should avoid driving or operating heavy machinery until these symptoms resolve.
Alcohol should be consumed with extreme caution. Chronic alcohol use can deplete magnesium and phosphorus, complicating the treatment. Furthermore, alcohol is a diuretic, which increases the risk of dehydration—a major risk factor for kidney damage when taking phosphate salts.
Do not stop taking this medication abruptly if you are using it to prevent kidney stones. Sudden discontinuation can cause the urine pH to rise quickly, potentially leading to a rapid recurrence of stone formation. If you need to stop the medication, your doctor will likely provide a tapering schedule or an alternative treatment.
> Important: Discuss all your medical conditions, especially heart disease, kidney disease, or a history of low calcium, with your healthcare provider before starting Sodium Phosphate, Monobasic.
There are certain medications that should never be used concurrently with Sodium Phosphate, Monobasic due to the risk of severe adverse events:
Sodium Phosphate, Monobasic can interfere with several laboratory measurements:
For each major interaction, the management strategy usually involves either avoiding the combination, adjusting the dose, or carefully timing the administration to prevent binding in the gut.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those you only take occasionally.
Sodium Phosphate, Monobasic must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by a specialist:
There is no known cross-sensitivity with unrelated drug classes. However, patients who have had an allergic reaction to any "Sodium Phosphate" product (including enemas or bowel preps) should not take the monobasic salt. It is also important to check the inactive ingredients (excipients) in specific tablet brands for sensitivities to dyes or fillers like lactose.
> Important: Your healthcare provider will evaluate your complete medical history, including your heart and kidney function, before prescribing Sodium Phosphate, Monobasic.
Sodium Phosphate, Monobasic is generally classified under FDA Pregnancy Category C. This means that adequate animal reproduction studies have not been conducted, and there are no well-controlled studies in pregnant women.
Phosphate is a natural component of breast milk. However, it is unknown if pharmacological doses of Sodium Phosphate, Monobasic significantly increase the concentration of phosphorus in milk or if this poses a risk to the nursing infant.
As discussed in the dosage section, pediatric use is restricted.
Patients over the age of 65 are at the highest risk for complications from Sodium Phosphate, Monobasic.
This is the most critical special population. For patients with mild-to-moderate impairment, doses must be reduced by 50% or more. For those with a GFR below 30, the drug is generally avoided. Dialysis does remove phosphate, but it cannot keep up with the intake of high-dose pharmacological supplements.
While the liver is not involved in the metabolism of this drug, patients with cirrhosis often have complex fluid balance issues (ascites). The sodium content of this medication can worsen fluid accumulation in the abdomen. Adjustments should be based on the patient's overall fluid status and renal function (Child-Pugh score is less relevant here than the MELD score for renal risk).
> Important: Special populations require individualized medical assessment and more frequent laboratory monitoring.
Sodium Phosphate, Monobasic acts as a source of the dihydrogen phosphate ion (H2PO4-). Its primary molecular action is the modulation of the chemical equilibrium in the urine and blood. By increasing the concentration of filtered phosphate in the renal tubules, it provides a buffer that accepts hydrogen ions, effectively lowering the pH of the urine. This acidification increases the solubility of calcium and phosphate ions, preventing them from precipitating into solid crystals. Additionally, in the blood, it serves to replenish the intracellular phosphate pool, which is essential for the synthesis of ATP, 2,3-diphosphoglycerate (2,3-DPG), and other high-energy phosphates necessary for cellular metabolism and oxygen delivery to tissues.
| Parameter | Value |
|---|---|
| Bioavailability | 70% - 90% (Oral) |
| Protein Binding | Negligible (Exists as free ions) |
| Half-life | 1 - 3 hours (Plasma); prolonged in renal failure |
| Tmax | 1 - 2 hours (Oral) |
| Metabolism | None (Inorganic salt) |
| Excretion | Renal (>90%), Fecal (10% unabsorbed) |
Sodium Phosphate, Monobasic is classified as a Calculi Dissolution Agent [EPC] and an Electrolyte Replenisher. It is related to other phosphate salts such as Potassium Phosphate and Dibasic Sodium Phosphate. Unlike the dibasic form (which is slightly basic), the monobasic form is acidic, making it the preferred choice for urinary acidification.
Common questions about Sodium Phosphate, Monobasic
Sodium Phosphate, Monobasic is primarily used by healthcare providers to prevent the formation of certain types of kidney stones by making the urine more acidic. It also serves as a supplement for patients with low levels of phosphorus in their blood, a condition known as hypophosphatemia. In some clinical settings, it is used as an anticoagulant for blood processing or as part of a bowel-cleansing regimen before medical procedures. Because it provides both sodium and phosphate, it helps maintain the body's electrolyte balance when used correctly. However, it must be taken under strict medical supervision to avoid complications.
The most frequently reported side effects are gastrointestinal in nature, including diarrhea, nausea, stomach cramps, and occasional vomiting. These occur because the phosphate salt acts osmotically, drawing water into the intestines. Some patients may also experience mild headaches or increased thirst due to the sodium content. Most of these symptoms are mild and tend to decrease as your body becomes accustomed to the medication. If these effects become severe or persistent, you should contact your doctor to discuss a possible dose adjustment. Taking the medication with food and plenty of water can often help minimize these issues.
It is generally advised to limit or avoid alcohol consumption while taking this medication. Alcohol acts as a diuretic, which can lead to dehydration and increase the risk of kidney strain when taking phosphate salts. Furthermore, chronic alcohol use can interfere with the way your body absorbs and processes minerals like magnesium and phosphorus, potentially making the medication less effective or more toxic. Dehydration is a major risk factor for the serious side effect known as acute phosphate nephropathy. Always discuss your alcohol intake habits with your healthcare provider before starting this treatment.
Sodium Phosphate, Monobasic is classified as FDA Pregnancy Category C, meaning its safety has not been fully established through controlled human studies. While phosphorus is a necessary mineral, pharmacological doses could potentially cause electrolyte imbalances that might affect the mother or the fetus. There is also a concern regarding the sodium load, which could contribute to high blood pressure or swelling during pregnancy. It should only be used if a doctor determines that the benefits clearly outweigh the potential risks. Pregnant women taking this medication will require frequent blood tests to monitor their mineral levels.
The onset of action depends on what the medication is being used for. If it is being used to acidify the urine for kidney stone prevention, you can expect a change in urinary pH within 2 to 4 hours after the first dose. For treating low blood phosphorus, levels typically begin to rise within 1 to 2 hours after oral ingestion. However, the full therapeutic benefit for stone prevention is a long-term process that requires consistent daily use. Your doctor will likely check your blood or urine levels within the first week of treatment to ensure the medication is working effectively.
You should not stop taking this medication without first consulting your healthcare provider. If you are taking it to prevent kidney stones, stopping abruptly can cause your urine to become less acidic very quickly, which may lead to a rapid recurrence of stone formation. For patients taking it for phosphorus deficiency, stopping suddenly could cause your phosphate levels to drop back into a dangerous range. If discontinuation is necessary, your doctor will usually provide a plan to gradually reduce your dose. Always follow the specific instructions provided by your medical team.
If you miss a dose, you should take it as soon as you remember. However, if it is almost time for your next scheduled dose, it is better to skip the missed dose and simply take the next one at the regular time. Never take two doses at once to make up for a missed one, as this can cause a sudden, dangerous spike in your phosphate levels. Maintaining a consistent schedule is important for keeping your urine pH stable. If you find yourself frequently forgetting doses, consider using a pill organizer or setting an alarm on your phone.
Sodium Phosphate, Monobasic does not typically cause an increase in body fat, but it can cause temporary weight gain due to water retention. Because the medication contains sodium, it can cause the body to hold onto extra fluid, leading to swelling (edema) in the legs, ankles, or hands. This fluid weight usually resolves if the dose is adjusted or the medication is stopped. If you notice a sudden, significant increase in weight (such as 3-5 pounds in a single week), you should contact your doctor. This could be a sign that the sodium is putting extra strain on your heart or kidneys.
Sodium Phosphate, Monobasic has several significant drug interactions that must be managed carefully. It should not be taken at the same time as antacids or calcium supplements, as these will bind to the phosphate and prevent it from working. It also interacts with certain blood pressure medications, like ACE inhibitors and diuretics, which can increase the risk of kidney damage. Always provide your doctor and pharmacist with a complete list of all the medications, vitamins, and herbal supplements you are taking. They can help you create a dosing schedule that avoids these interactions.
Yes, Sodium Phosphate, Monobasic is widely available as a generic medication, though it is most commonly found in combination with Sodium Phosphate, Dibasic or as a potassium/sodium phosphate blend. Generic versions are typically much more cost-effective than brand-name products like K-Phos. While the active ingredients are the same, different manufacturers may use different inactive fillers, so if you have specific allergies, you should check the label carefully. Your pharmacist can help you identify the generic version that is equivalent to the brand your doctor has prescribed.